Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2025-12-25 @ 5:35 PM
Study NCT ID:
NCT05872204
Status:
RECRUITING
Last Update Posted:
2025-03-19
First Post:
2023-05-02
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Abemaciclib and Letrozole in Patients With Estrogen Receptor-positive Rare Ovarian Cancer
Sponsor:
Universitaire Ziekenhuizen KU Leuven
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-05-02
First Submit QC Date:
None
Study First Post Date:
2023-05-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-14
Last Update Post Date:
2025-03-19
Last Update Post Date Type:
ACTUAL